Lyell Immunopharma LYEL
NASDAQ LYEL
$16.86 +0.11 (+0.66%)
At close: Nov 11, 2026 · 4:00 PM EST

Lyell Immunopharma (LYEL) Asset Writedowns and Impairment (2020 - 2025)

Updated

Lyell Immunopharma (LYEL) posted Asset Writedowns and Impairment of $1.44 million for FY2025, down 97.2% from $51.3 million in FY2024.

Analysis

Lyell Immunopharma (LYEL) Asset Writedowns and Impairment (2020 - 2025) Analysis & Trends

  • Annual Asset Writedowns and Impairment shows a four-year compound annual growth rate of -55.4% (FY2021 to FY2025).
  • Business Quant data shows LYEL's Asset Writedowns and Impairment at $51.3 million in FY2024 and $36.4 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Lyell Immunopharma 411.74 Mn -470.71 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1.44 Mn
Dec 31, 2024 38.30 Mn
Mar 31, 2024 13.00 Mn
Dec 31, 2022 -5.00 Mn
Sep 30, 2022 5.00 Mn
Jun 30, 2022 6,000.00
Mar 31, 2022 5,000.00
Jun 30, 2021 98,000.00
Mar 31, 2021 4.21 Mn
Dec 31, 2020 -2.96 Mn
Sep 30, 2020 57,000.00
API Access

Lyell Immunopharma Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=LYEL&period=max&api_key=YOUR_API_KEY